SEATTLE, Wash. and VANCOUVER, British Columbia, September 3, 2020 – – Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will present at two upcoming investor conferences.
- H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16th
- John Bencich, Chief Financial and Operating Officer, will present a virtual corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16th at 3:30 PM ET. A live webcast of the presentation can be accessed by visiting http://ir.achievelifesciences.com/events-and-webcasts. A replay of the presentation will be archived on Achieve’s website following the conference.
- Lake Street Capital Markets 4th Annual Best Ideas Growth (BIG4) Conference on Thursday, September 17th
- Management will be hosting one-on-one meetings with investors at the Lake Street Capital Markets 2020 Best Ideas Growth (BIG4) Conference, to be held virtually on Thursday, September 17th, 2020. This conference is an invitation-only event, featuring over 50 dynamic, small-cap companies interacting with top institutional investors. For those interested in arranging a one-on-one meeting with Achieve management, please contact your Lake Street Capital Markets representative.
About Achieve and Cytisinicline
Tobacco use is currently the leading caus